Cytokine and growth factor profiling in patients with the metabolic syndrome

The metabolic syndrome (MetS) is associated with a pro-inflammatory milieu that may partially account for its association with an increased cardiovascular risk. We aimed to (1) evaluate the serum concentrations of twelve cytokines and growth factors (epidermal growth factor (EGF), interferon-γ (IFN-γ), IL-1α/-1β/-2/-4/-6/-8/-10, monocyte chemoattractant protein-1 (MCP-1), TNF-α and vascular endothelial growth factor (VEGF)) in 303 individuals with or without the MetS; and (2) explore their relationship with the presence of the MetS. Patients with the MetS had significantly higher serum concentrations of IFN-γ, EGF, IL-1α/-1β/-2/-4/-6/-8/-10, MCP-1 and TNF-α, whilst serum VEGF concentrations were markedly lower compared with the control group (e.g. 38·55 v. 82·18 pg/ml; P< 0·05). Amongst these parameters, IFN-γ and IL-1α emerged as the most significant independent predictors of the MetS. In conclusion, our findings demonstrate that patients with the MetS had an altered blood cytokine and growth factor profile that may partially account for its adverse clinical outcomes. Further prospective studies in larger multi-centre settings are required to unravel the role and association of the emerging biomarkers with the MetS and their implication in therapeutic intervention.

[1]  J. Um,et al.  Functional Polymorphism of IL-1 Alpha and Its Potential Role in Obesity in Humans and Mice , 2011, PloS one.

[2]  Takahisa Kondo,et al.  Comparison of Circulating Adiponectin and Proinflammatory Markers Regarding Their Association With Metabolic Syndrome in Japanese Men , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[3]  A. Chawla,et al.  Connecting type 1 and type 2 diabetes through innate immunity. , 2012, Cold Spring Harbor perspectives in medicine.

[4]  A. Jungbauer,et al.  Anti-inflammatory properties of culinary herbs and spices that ameliorate the effects of metabolic syndrome. , 2012, Maturitas.

[5]  D. Fearon,et al.  Inflammation and cardiovascular disease: role of the interleukin-1 receptor antagonist. , 2008, Circulation.

[6]  C. Mathieu,et al.  Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. , 2007, Diabetes research and clinical practice.

[7]  H. Minuk,et al.  Metabolic syndrome. , 2005, Journal of insurance medicine.

[8]  R. Eckel,et al.  The metabolic syndrome and inflammation. , 2004, Metabolic syndrome and related disorders.

[9]  L Wood,et al.  Adipose tissue tumor necrosis factor and interleukin-6 expression in human obesity and insulin resistance. , 2001, American journal of physiology. Endocrinology and metabolism.

[10]  M. Blagosklonny.  TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists , 2013, Cell Death and Disease.

[11]  E. Ford.  The metabolic syndrome and C-reactive protein, fibrinogen, and leukocyte count: findings from the Third National Health and Nutrition Examination Survey. , 2003, Atherosclerosis.

[12]  L. Groop,et al.  Cardiovascular morbidity and mortality associated with the metabolic syndrome. , 2001, Diabetes care.

[13]  Roisin M Molloy,et al.  Automation of biochip array technology for quality results , 2005, Clinical chemistry and laboratory medicine.

[14]  S. Baik,et al.  Comparison of serum concentrations of C-reactive protein, TNF-alpha, and interleukin 6 between elderly Korean women with normal and impaired glucose tolerance. , 2004, Diabetes research and clinical practice.

[15]  K. Thiel,et al.  The Epidermal Growth Factor Receptor and Its Ligands in Cardiovascular Disease , 2013, International journal of molecular sciences.

[16]  Lijun Yao,et al.  Anthocyanin-rich fractions from red raspberries attenuate inflammation in both RAW264.7 macrophages and a mouse model of colitis , 2014, Scientific Reports.

[17]  S. Grundy,et al.  Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Arteriosclerosis, Thrombosis and Vascular Biology.

[18]  John V Lamont,et al.  Development of a high-throughput automated analyzer using biochip array technology. , 2005, Clinical chemistry.

[19]  Y. Miyazaki,et al.  Tumor necrosis factor α and insulin resistance in obese type 2 diabetic patients , 2003, International Journal of Obesity.

[20]  Haiyuan Yu,et al.  Detecting overlapping protein complexes in protein-protein interaction networks , 2012, Nature Methods.

[21]  J. Fernández-Real,et al.  Insulin resistance and chronic cardiovascular inflammatory syndrome. , 2003, Endocrine reviews.

[22]  Faloia Emanuela,et al.  Inflammation as a Link between Obesity and Metabolic Syndrome , 2012, Journal of nutrition and metabolism.

[23]  P. Scherer,et al.  Adipose tissue, inflammation, and cardiovascular disease. , 2005, Circulation research.

[24]  A. Shen,et al.  Interferon gamma (IFN-γ) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription , 2011, Nucleic acids research.

[25]  S. Grundy,et al.  Clinical Management of Metabolic Syndrome: Report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association Conference on Scientific Issues Related to Management , 2004, Circulation.

[26]  A. D. de Craen,et al.  Low production capacity of interleukin-10 associates with the metabolic syndrome and type 2 diabetes : the Leiden 85-Plus Study. , 2002, Diabetes.

[27]  R. Gaynor,et al.  Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference , 2004, Oncogene.

[28]  M. Margaglione,et al.  Low-grade inflammation may play a role in the etiology of the metabolic syndrome in patients with coronary heart disease: the HIFMECH study. , 2004, Metabolism: clinical and experimental.

[29]  V. Mehra,et al.  Cytokines and cardiovascular disease , 2005, Journal of leukocyte biology.

[30]  H. Brenner,et al.  Association between C-reactive protein and features of the metabolic syndrome: a population-based study. , 2000, Diabetes care.

[31]  Esko Vanninen,et al.  Multiple Abnormalities in Glucose and Energy Metabolism and Coordinated Changes in Levels of Adiponectin, Cytokines, and Adhesion Molecules in Subjects With Metabolic Syndrome , 2004, Circulation.

[32]  S. Yaturu,et al.  Relationship of elevated osteoprotegerin with insulin resistance, CRP, and TNF-alpha levels in men with type 2 diabetes. , 2008, Cytokine.

[33]  A. Bonnefond,et al.  Associations of vascular endothelial growth factor (VEGF) with adhesion and inflammation molecules in a healthy population. , 2013, Cytokine.

[34]  A. Gotto,et al.  The metabolic syndrome and risk of major coronary events in the Scandinavian Simvastatin Survival Study (4S) and the Air Force/Texas Coronary Atherosclerosis Prevention Study (AFCAPS/TexCAPS). , 2004, The American journal of cardiology.

[35]  M. Ghayour-Mobarhan,et al.  Dietary intake of patients with angiographically defined coronary artery disease and that of healthy controls in Iran , 2014, European Journal of Clinical Nutrition.

[36]  Y. Miyazaki,et al.  Tumor necrosis factor alpha and insulin resistance in obese type 2 diabetic patients. , 2003, International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity.

[37]  Nancy R Cook,et al.  C-Reactive Protein, the Metabolic Syndrome, and Risk of Incident Cardiovascular Events: An 8-Year Follow-Up of 14 719 Initially Healthy American Women , 2003, Circulation.

[38]  R. Gaynor,et al.  Identification of NF-κB-regulated genes induced by TNFα utilizing expression profiling and RNA interference , 2003, Oncogene.

[39]  G. Shi,et al.  Mast cells and metabolic syndrome. , 2012, Biochimica et biophysica acta.

[40]  J. Gussekloo,et al.  The Leiden 85-plus Study , 2000 .

[41]  M. Mirarefin,et al.  Association of metabolic syndrome with inflammatory mediators in women with previous gestational diabetes mellitus , 2013, Journal of Diabetes & Metabolic Disorders.

[42]  Nathan D. Wong,et al.  Impact of the Metabolic Syndrome on Mortality From Coronary Heart Disease, Cardiovascular Disease, and All Causes in United States Adults , 2004, Circulation.

[43]  D. Song,et al.  Serum tumor necrosis factor-alpha levels and components of the metabolic syndrome in obese adolescents. , 2004, Metabolism: clinical and experimental.

[44]  G. Hotamisligil,et al.  Nutrient sensing and inflammation in metabolic diseases , 2008, Nature Reviews Immunology.

[45]  A. Avan,et al.  An imbalance in serum concentrations of inflammatory and anti-inflammatory cytokines in hypertension. , 2014, Journal of the American Society of Hypertension : JASH.

[46]  I. S. Wood,et al.  Adipokines: inflammation and the pleiotropic role of white adipose tissue , 2004, British Journal of Nutrition.

[47]  Fernando Costa,et al.  Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute scientific statement. , 2006, Current opinion in cardiology.

[48]  Jukka T Salonen,et al.  The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. , 2002, JAMA.